GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 74 filers reported holding GALENA BIOPHARMA INC in Q1 2016. The put-call ratio across all filers is 0.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $11,000 | -69.4% | 29,600 | -61.9% | 0.00% | -100.0% |
| Q2 2016 | $36,000 | -64.4% | 77,600 | +4.4% | 0.00% | -66.7% |
| Q1 2016 | $101,000 | -26.8% | 74,300 | -21.2% | 0.00% | -25.0% |
| Q4 2015 | $138,000 | -4.8% | 94,300 | +2.6% | 0.00% | 0.0% |
| Q3 2015 | $145,000 | -37.8% | 91,900 | -32.9% | 0.00% | -33.3% |
| Q2 2015 | $233,000 | +30.9% | 136,900 | +6.9% | 0.01% | +20.0% |
| Q1 2015 | $178,000 | -27.0% | 128,100 | -20.8% | 0.01% | -28.6% |
| Q4 2014 | $244,000 | -42.6% | 161,800 | -21.6% | 0.01% | -46.2% |
| Q3 2014 | $425,000 | -22.6% | 206,300 | +14.8% | 0.01% | -23.5% |
| Q2 2014 | $549,000 | +185.9% | 179,699 | +134.3% | 0.02% | +183.3% |
| Q1 2014 | $192,000 | -54.4% | 76,699 | -9.6% | 0.01% | -53.8% |
| Q4 2013 | $421,000 | +537.9% | 84,800 | +192.4% | 0.01% | +550.0% |
| Q3 2013 | $66,000 | – | 29,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hoxton Financial, Inc. | 50,000 | $74,000 | 0.04% |
| Alyeska Investment Group, L.P. | 1,593,277 | $2,342,000 | 0.02% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 31,000 | $46,000 | 0.02% |
| GROUP ONE TRADING, L.P. | 1,346,904 | $1,980,000 | 0.02% |
| Matisse Capital | 17,000 | $25,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 15,000 | $22,000 | 0.01% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 12,150 | $18,000 | 0.01% |
| EQUITEC SPECIALISTS, LLC | 19,700 | $29,000 | 0.01% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 153,375 | $225,000 | 0.00% |
| OPPENHEIMER & CO INC | 94,300 | $138,000 | 0.00% |